I’m Eyeing 2 Biopharma Stocks Amid Choppy Market Action
These small-cap biotechs offer core businesses that fund a much bigger opportunity.
Market Indecision: War Uncertainty, Wacky Econ Data, Fake News?
Investors are stuck dealing with more questions over the state of the Strait, economic data that doesn’t quite make sense, and accusations of fake news.
The Risk of a Bull Trap Is Increasing
The market mood has improved this week, but fundamentals are still under debate.
With Talk of S&P 8000, Here Are Some Sentiment Measures to Watch
With the S&P 500 setting new highs, the bears have left the building. Here’s what I’m paying attention to.
Momentum Fizzles After 2 Big Days, but Here’s What Indexes Didn’t Show
There was still plenty of speculative action in small stocks, but the indexes needed a rest.
Party on Wall St.! Palantir, Micron, SK Hynix Invited! (SpaceX, AMD Not…)
Are ‘Happy Days’ here again? Let’s check the stats, charts and the action on Wall Street. Also, guess who’s getting beat up along the way….
Bulls Got a Green Light, But Here’s Why They Shouldn’t Floor It
We have a technical follow-through day, however, disciplined buying is paramount.
Bulls Rush In
Just a week ago, investors were anxious. Now, they’re rushing into stocks, hoping to get exposure any way they can.
Trump’s Ultimatum, Manufacturing Cranks Up, Palantir Pops
Trump means it … this time … on Iran; U.S. manufacturing churns higher, and Palantir? Wow!
